Borosil Scientific Limited’s Nomination and Remuneration Committee (NRC) has approved the grant of 18,700 stock options under its Employee Stock Option Scheme. The decision was taken during a meeting held on May 20, 2026. Each stock option entitles the holder to apply for one equity share of the company with a face value of Re. 1.

The options have been granted at a price of Rs. 108 per share. This pricing represents approximately a 10% discount on the market price, which was determined based on the closing price on the National Stock Exchange of India Limited (NSE) on May 19, 2026. The NSE was selected as the reference exchange as it recorded the highest trading volume in the company's shares on the preceding trading day.

The vesting schedule for these options is structured over a four-year period. The options will vest in equal annual installments of 25% each, starting from the first anniversary of the grant date. The exercise period for the options is set at five years from the date of vesting for the respective tranches.

Key Details of the Grant

The following table outlines the specific details regarding the grant of stock options:

Vesting Schedule

The options granted will vest according to the following timeline:

The company confirmed that the scheme is in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. As of the date of the intimation, no options have been vested, exercised, or lapsed, and no money has been realized from the exercise of options.

Borosil Scientific Limited promoters have submitted a formal declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming that no encumbrance was created on any promoter-held equity shares during the financial year ended March 31, 2026. The declaration was filed by Pradeep Kumar Kheruka on behalf of himself and all other promoters and persons acting in concert (PAC). The filing was addressed to BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited.

Key Declaration Highlights

The declaration confirms that the promoters, along with persons acting in concert, have not made any encumbrance, directly or indirectly, on the equity shares held by them in Borosil Scientific Limited during the financial year ended March 31, 2026. As on March 31, 2026, NIL equity shares of Borosil Scientific Limited are encumbered by the promoters or PAC.

Persons Acting in Concert

The declaration covers the following promoters and persons acting in concert (PAC) of Borosil Scientific Limited:

• Kiran Kheruka
• Rekha Kheruka
• Pradeep Kumar Kheruka
• Shreevar Kheruka
• Gujarat Fusion Glass LLP
• Spartan Trade Holdings LLP
• Borosil Holdings LLP
• Associated Fabricators LLP
• Sonargaon Properties LLP
• Croton Trading Private Limited
• Alaknanda Ruia

Regulatory Compliance

This declaration is a mandatory annual compliance requirement under SEBI's Takeover Regulations, obligating promoters to confirm the status of encumbrance on their shareholding at the end of each financial year. The filing was submitted to both stock exchanges — BSE Limited and the National Stock Exchange of India Ltd — as well as to the Audit Committee of Borosil Scientific Limited, in accordance with the prescribed regulatory framework.